Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$9.41 - $12.03 $40,557 - $51,849
-4,310 Reduced 27.27%
11,495 $122,000
Q3 2022

Nov 08, 2022

SELL
$7.36 - $9.15 $90,859 - $112,956
-12,345 Reduced 43.85%
15,805 $135,000
Q1 2022

May 10, 2022

BUY
$11.35 - $13.7 $319,502 - $385,655
28,150 New
28,150 $327,000
Q4 2021

Feb 14, 2022

SELL
$11.95 - $13.34 $326,235 - $364,182
-27,300 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$12.84 - $17.26 $147,595 - $198,403
11,495 Added 72.73%
27,300 $407,000
Q4 2020

Feb 17, 2021

BUY
$14.61 - $17.59 $230,911 - $278,009
15,805 New
15,805 $238,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $55.4M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Wms Partners, LLC Portfolio

Follow Wms Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.